Indeed, lipid metabolism deficiency has been investigated in lipocalin-type PGD2 synthase (L-Pgds)-knockout (KO) mice and kidney dysfunction patients, which have a susceptibility to glucose intolerance, accelerated insulin resistance, and aggravated obesity [36, 37]. The gene discussed is PTGDS; the disease is obesity due to melanocortin 4 receptor deficiency.